Feasibility of remote speech analysis in evaluation of dynamic fluid overload in heart failure patients undergoing haemodialysis treatment.


Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
08 2021
Historique:
revised: 02 03 2021
received: 06 12 2020
accepted: 01 04 2021
pubmed: 7 5 2021
medline: 29 10 2021
entrez: 6 5 2021
Statut: ppublish

Résumé

This study aimed to assess the ability of a voice analysis application to discriminate between wet and dry states in chronic heart failure (CHF) patients undergoing regular scheduled haemodialysis treatment due to volume overload as a result of their chronic renal failure. In this single-centre, observational study, five patients with CHF, peripheral oedema of ≥2, and pulmonary congestion-related dyspnoea, undergoing haemodialysis three times per week, recorded five sentences into a standard smartphone/tablet before and after haemodialysis. Recordings were provided that same noon/early evening and the next morning and evening. Patient weight was measured at the hospital before and after each haemodialysis session. Recordings were analysed by a smartphone application (app) algorithm, to compare speech measures (SMs) of utterances collected over time. On average, patients provided recordings throughout 25.8 ± 3.9 dialysis treatment cycles, resulting in a total of 472 recordings. Weight changes of 1.95 ± 0.64 kg were documented during cycles. Median baseline SM prior to dialysis was 0.87 ± 0.17, and rose to 1.07 ± 0.15 following the end of the dialysis session, at noon (P = 0.0355), and remained at a similar level until the following morning (P = 0.007). By the evening of the day following dialysis, SMs returned to baseline levels (0.88 ± 0.19). Changes in patient weight immediately after dialysis positively correlated with SM changes, with the strongest correlation measured the evening of the dialysis day [slope: -0.40 ± 0.15 (95% confidence interval: -0.71 to -0.10), P = 0.0096]. The fluid-controlled haemodialysis model demonstrated the ability of the app algorithm to identify cyclic changes in SMs, which reflected bodily fluid levels. The voice analysis platform bears considerable potential as a harbinger of impending fluid overload in a range of clinical scenarios, which will enhance monitoring and triage efforts, ultimately optimizing remote CHF management.

Identifiants

pubmed: 33955187
doi: 10.1002/ehf2.13367
pmc: PMC8318440
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2467-2472

Informations de copyright

© 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

Hemodial Int. 2013 Oct;17(4):633-8
pubmed: 23461740
N Engl J Med. 2010 Dec 9;363(24):2301-9
pubmed: 21080835
Nat Rev Nephrol. 2018 Oct;14(10):626-635
pubmed: 30143787
J Voice. 2014 Mar;28(2):226-30
pubmed: 24275458
J Biomed Inform. 2018 Jul;83:103-111
pubmed: 29852317
Eur Arch Otorhinolaryngol. 2018 Nov;275(11):2755-2761
pubmed: 30132071
IEEE Trans Biomed Eng. 2015 Apr;62(4):1185-94
pubmed: 25532164
Ann Otol Rhinol Laryngol. 1997 Jul;106(7 Pt 1):533-43
pubmed: 9228851
Circulation. 2011 May 3;123(17):1873-80
pubmed: 21444883
Ren Fail. 2015 Mar;37(2):268-72
pubmed: 25457372
J Voice. 2005 Jun;19(2):290-5
pubmed: 15907443
ESC Heart Fail. 2021 Aug;8(4):2467-2472
pubmed: 33955187
Mayo Clin Proc. 2018 Jul;93(7):840-847
pubmed: 29656789
Nephron. 1997;75(4):394-401
pubmed: 9127325
Front Hum Neurosci. 2011 Jan 19;4:237
pubmed: 21267429
Dis Mon. 2019 Apr;65(4):104-108
pubmed: 30274929
JAMA Intern Med. 2016 Mar;176(3):310-8
pubmed: 26857383
J Geriatr Cardiol. 2013 Sep;10(3):253-7
pubmed: 24133513
J Acoust Soc Am. 2017 Oct;142(4):EL401
pubmed: 29092550
J Laryngol Otol. 2012 Aug;126(8):867-9
pubmed: 22804861
Ann Thorac Med. 2015 Jul-Sep;10(3):158-68
pubmed: 26229557
Nephron Clin Pract. 2006;103(4):c144-8
pubmed: 16636582
Lancet. 2011 Feb 19;377(9766):658-66
pubmed: 21315441
Isr J Med Sci. 1997 Feb;33(2):134-8
pubmed: 9254876

Auteurs

Offer Amir (O)

Department of Cardiology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

Stefan D Anker (SD)

Department of Cardiology (CVK) and Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité-Universitätsmedizin Berlin, Augustenburger Platz, Berlin, D-13353, Germany.

Ittamar Gork (I)

Department of Cardiology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

William T Abraham (WT)

Division of Cardiovascular Medicine, The Ohio State University, Columbus, OH, USA.

Sean P Pinney (SP)

University of Chicago, Chicago, IL, USA.

Daniel Burkhoff (D)

Cardiovascular Research Foundation, New York, NY, USA.

Ilan D Shallom (ID)

Cordio Medical Ltd., Or Yehuda, Israel.

Ronit Haviv (R)

Cordio Medical Ltd., Or Yehuda, Israel.

Elazer R Edelman (ER)

Institute for Medical Engineering and Science, MIT, Cambridge, MA, USA.

Chaim Lotan (C)

Department of Cardiology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH